Charts that show total weight change by injection site and average weekly loss by site can reveal whether one area is working differently for you
The reasons may be related to the fact that AKI is a rare adverse reaction, the observation period of clinical trials is limited, and the adverse reactions are easily covered by the rapid progress of diabetic kidney disease(DKD).In this study, the adverse signals of exenatide, dulaglutide, and albiglutide in AKI were not found, but some studies have confirmed the close connection between exenatide and AKI (38), and dulaglutide is also considered to cause a decrease in body fluid intake (14), which may be one of the reasons for AKI (28)
Adding glycine supplementation has shown additional benefits for users on GLP-1 medications, supporting muscle preservation and metabolic health during weight loss
Thumbigere-Math V, Johnson DK
See more in our infographic: